Skip to content
Axe Capital logo Axe Capital Trading News

SoundHound's Business Is Booming. Can the $7 Stock Double by September 2027?

2026-09-04 20:07 Keithen Drury The Motley Fool Positive Axe Cap view: Selective EquitiesEarningsTechnologyAISemiconductorsHealthcare SOUNSOUNW

Axe Cap view

SoundHound AI: High Growth but Execution Will Tell

SoundHound’s strong revenue growth offers promise, but its path to doubling shares by 2027 remains uncertain.

SoundHound AI’s 45% revenue growth and sub-15x sales valuation sound attractive at first glance. For South African investors, this underscores how AI tech firms poised for enterprise adoption can command rapid growth. But the devil lies in execution. The company targets high-value sectors like banking and healthcare, which are notoriously slow to adopt new tech at scale. Without materializing these enterprise contracts, strong trial numbers might not convert to lasting revenue. Locally, this mirrors how listed banks—Standard Bank, FirstRand, Nedbank—are cautious with tech upgrades despite clear promise. Meanwhile, SoundHound’s US dollar-denominated revenues add exposure to USD/ZAR volatility, especially with rand swings tied closely to global risk sentiment. If the rand weakens, the company’s revenue reported in dollars could look inflated when converted. this is just our opinion and not financial advice

How I would invest

Watch SoundHound closely but avoid buying until it secures sizeable enterprise deals. For rand hedge, consider some USD/ZAR exposure instead. Confidence remains moderate given execution risks.

What I would watch
  • SOUN
  • USD/ZAR
What could go wrong
  • Enterprise contracts may not materialize
  • Currency volatility affecting reported results
How strongly I feel

5/10

SoundHound AI's stock has fallen from nearly $25 to under $7 per share, but the company's business fundamentals remain strong with 45% year-over-year revenue growth to $62 million in Q2. The company combines AI with speech recognition for restaurant automation and aims to expand into banking, healthcare, and insurance customer service. While the stock is fairly valued at less than 15x sales, its ability to double depends on whether enterprise contracts materialize, making it a high-risk, high-reward investment.

Our take is based on reporting first published by The Motley Fool.

Read the original story